Researchers from The Scripps Research Institute (TSRI) and PATH have shed light on how the human immune system recognizes the malaria parasite. Read more...
MVI PortfolioWe strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity.
Evaluation technology projectsWe partner to develop and optimize new assays and challenge models and support reference and service laboratories.
RTS,SGhana, Kenya, and Malawi to take part in WHO malaria vaccine pilot programme
PATH and Walter Reed Army Institute of Research announce largest-ever controlled malaria infection study
8 Sep 2017
Optimizing Direct Membrane and Direct Skin Feeding Assays for Plasmodium falciparum Transmission-Blocking Vaccine Trials in Bancoumana, Mali
5 Sep 2017
PATH partners with the Mahidol Oxford Tropical Medicine Research Unit on first study of the RTS,S malaria vaccine in Asia
9 Aug 2017
Return on innovation: Why global health R&D is a smart investment for the United States
19 Jul 2017